horn icon

Amneal Launches First-of-Its-Kind Multichambered Bag for Oncology with TEPADINA® (Thiotepa) 200mg

September 2, 2025 – Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced that it has begun U.S. commercialization of TEPADINA® (thiotepa) for Injection 200 mg in a patented multichambered bag…

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Amneal Launches First-of-Its-Kind Multichambered Bag for Oncology with TEPADINA® (Thiotepa) 200mg

Name
Address
Subscribe